Next Sequence Overview

  • Investor Type
  • Accelerator/​Incubator

  • Status
  • Active

  • Professionals
  • 3

Professionals

  • Investments
  • 8

  • Portfolio
  • 6

  • Exits
  • 1

Exits

Next Sequence General Information

Company Description

Founded in 2021, Next Sequence is an accelerator firm based in New York. The firm provides incubation services and makes venture capital investments in disruptive companies in the synthetic biology sector.

Business Details

Year Founded
2021
Investor Status
Actively Seeking New Investments
Primary Investor Type
Accelerator/Incubator
Other Investor Types
Venture Capital
Corporate Office
  • 222 Broadway
  • 19th Floor
  • New York, NY 10012
  • United States

Next Sequence Investments (8)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Biomemory 13-Nov-2024 Early Stage VC Storage (IT) Generating Revenue
PentaBind 15-Oct-2024 Drug Discovery Pre-Clinical Trials
Eden Genetics 01-Jan-2024 Biotechnology Generating Revenue
Matricis.ai 01-Jan-2024 Diagnostic Equipment Generating Revenue
NeuroX1 01-Jan-2024 Drug Discovery Pre-Clinical Trials
ImmunoMind 01-Sep-2023 Drug Discovery Out of Business
ArgenTAG 01-Jan-2022 Accelerator/Incubator Biotechnology Generating Revenue
Biomemory 01-Jan-2022 Accelerator/Incubator Storage (IT) Generating Revenue
To view Next Sequence’s complete investments history, request access »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Next Sequence Exits (1)

Company Name Exit Date Exit Type Exit Size
ImmunoMind 28-Sep-2026
To view Next Sequence’s complete exits history, request access »

Next Sequence Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Next Sequence FAQs

  • What is Next Sequence?

    Founded in 2021, Next Sequence is an accelerator firm based in New York.

  • When was Next Sequence founded?

    Next Sequence was founded in 2021.

  • Where is Next Sequence headquartered?

    Next Sequence is headquartered in New York, NY.

  • How many investments has Next Sequence made?

    Next Sequence has made 8 investments.

  • What has Next Sequence invested in?

    Next Sequence has made numerous investments in companies like Biomemory, PentaBind, and Eden Genetics within the Storage (IT), Drug Discovery, and Biotechnology industries.

  • What has Next Sequence invested in recently?

    Next Sequence's latest investment was on 13-Nov-2024 in Biomemory, a company within the Storage (IT) industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process